Pregnancy of unknown location with rising hCG
Priya is a 28-year-old G2P1 with a 6-week history of amenorrhoea and 2 days of mild left iliac fossa pain. She has had no vaginal bleeding and no syncope. Her previous pregnancy was an uncomplicated vaginal delivery. She is hemodynamically stable: pulse 78, BP 112/70. Abdominal examination is soft with mild left lower quadrant tenderness and no rebound. Transvaginal ultrasound shows an empty uterus, no adnexal mass, no free fluid, and no intrauterine gestational sac. Serum beta-hCG is 1,250 IU/L and serum progesterone is 7 ng/mL. She is Rh positive. She lives 30 minutes from the hospital and has a reliable phone. She is unsure whether she wants more children and asks about methotrexate.
1. What is the diagnosis and what is your immediate plan?
Read the worked answer
This is a pregnancy of unknown location (PUL): the uterus is empty, there is no adnexal mass or free fluid, and the beta-hCG is above the discriminatory zone for many units but not high enough to exclude an early intrauterine pregnancy. The progesterone of 7 ng/mL suggests a non-viable pregnancy, but it is not diagnostic. She is stable, so the immediate plan is expectant with serial beta-hCG measurements every 48 hours and repeat transvaginal ultrasound. Do not give methotrexate yet, because a viable intrauterine pregnancy has not been excluded and there is no confirmed ectopic. If the hCG falls, this is a failing PUL; if it plateaus or rises, ectopic pregnancy becomes more likely; if it rises appropriately and she remains well, repeat ultrasound when the hCG is above the discriminatory zone. Give clear safety-net advice and ensure she can return.
2. What are the criteria for methotrexate, and what would make you choose surgical management?
Read the worked answer
Methotrexate is considered for a hemodynamically stable woman with a confirmed ectopic pregnancy or a persistent PUL, no fetal cardiac activity, an adnexal mass usually <4 cm, hCG <5,000 IU/L, no significant haemoperitoneum, normal renal and liver function, no breastfeeding, and reliable follow-up. It is also used for some non-tubal ectopics only with specialist input. Surgery is preferred if she is unstable, has severe pain, rupture or significant free fluid, hCG >5,000 IU/L, fetal cardiac activity, a large mass, contraindications to methotrexate, or cannot comply with follow-up. In this case, because the diagnosis is PUL and she is stable, methotrexate is not yet indicated. If serial hCG shows a plateau or rise and no intrauterine pregnancy appears, methotrexate or surgery can be discussed. If she wants more children, discuss fertility and recurrence risk.
3. How would you counsel her about follow-up and red flags?
Read the worked answer
Explain that the pregnancy's location is not yet known and that some PULs resolve, some are early miscarriages and some are ectopics. She needs repeat hCG in 48 hours and possibly further scans; follow-up continues until the hCG is non-pregnant. Advise her to avoid strenuous activity and to return immediately with severe abdominal pain, shoulder-tip pain, dizziness, syncope, heavy vaginal bleeding or fever. She should not travel far from hospital while follow-up is incomplete. If methotrexate becomes necessary, explain that it is not effective if a viable intrauterine pregnancy is present, that she must avoid pregnancy for at least 3 months, avoid alcohol and folate supplements, and use contraception. If surgery is needed, discuss the risk of tubal surgery and future fertility. Document that she understands the plan and has a contact number.